ProAssurance Corporation (PRA)
NYSE: PRA
· Real-Time Price · USD
23.19
0.04 (0.17%)
At close: May 30, 2025, 3:59 PM
23.21
0.09%
After-hours: May 30, 2025, 05:29 PM EDT
ProAssurance Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Segregated Portfolio Cell Reinsurance Revenue | 52.7M | 61.55M | 69.81M | 63.69M | 66.35M | 78.56M | 73.94M | 453.92M | 457.82M | 443.31M | 492.73M |
| Segregated Portfolio Cell Reinsurance Revenue Growth | -14.38% | -11.84% | +9.61% | -4.01% | -15.54% | +6.25% | -83.71% | -0.85% | +3.27% | -10.03% | n/a |
| Specialty Property and Casualty Revenue | 747.94M | 755.82M | 769.77M | 695.01M | 477.37M | 499.06M | 491.79M | n/a | n/a | n/a | n/a |
| Specialty Property and Casualty Revenue Growth | -1.04% | -1.81% | +10.76% | +45.59% | -4.35% | +1.48% | n/a | n/a | n/a | n/a | n/a |
| Workers' Compensation Insurance Segment Revenue | 167.61M | 160.03M | 166.37M | 164.6M | 171.77M | n/a | n/a | n/a | n/a | n/a | n/a |
| Workers' Compensation Insurance Segment Revenue Growth | +4.73% | -3.81% | +1.08% | -4.18% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -238.71M | 174.16M | -1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -28.74M | -78.71M | n/a | n/a | n/a | -30.22M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 29.02M | n/a | n/a | n/a | n/a |
| Selling, General, and Administrative Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100.00% | -237.06% | -17516.30% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100.00% | -63.49% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |